vedolizumab
takeda
[' uc ', 'vedo', ' vedo']
 reporting on active uc with pnr to vedo (+cs). what s your preferred choice? i ve been very happy with jaki still we need to consider the barriers to prescribe it in patients never exposed to anti-tnfs in the us. very interesting discussion at #ecco23 
MD, PhD, Gastroenterologist, Clinical Director IBD Center Santa Cruz Hospital